The 2026 Nobel Prize in Chemistry was awarded to French and Japanese scientists for deciphering chemical asymmetry. What is chemical homochirality, and what contributions did their discoveries make?

Chemical reactions in life are termed 'homochirality' by chemists—a word derived from Greek roots meaning 'same' and 'hand.' Just like our hands, all amino acids exist as two mirror-image isomers; yet only one of these appears in the proteins within your cells, while the other is exceedingly rare in nature. For a long time, chemists have been puzzled by how homochirality arises. When they attempted chemical reactions capable of producing both mirror-image molecules, test tubes invariably yielded equal amounts of both forms. Chemists, however, strive to produce only one mirror-image form—because when designing molecules that interact with biological systems (e.g., drugs), only one enantiomer delivers the desired effect. Thanks to laureates Henri Kagan and Kensō Soai, we now understand how homochirality emerges. Their discoveries are decisive for chemists designing pharmaceutical syntheses. Henri Kagan, the 2026 Nobel Laureate, discovered a novel way to control chemical reactions, enabling the generation of significantly greater excesses of one enantiomer than previously thought possible. This breakthrough is revolutionary for chemists developing reactions to manufacture pharmaceuticals, fragrances, flavors, and new materials. Kensō Soai designed the first chemical reaction that produces exclusively one possible mirror-image isomer. Aside from life itself, no one had ever achieved this feat before. The Soai reaction (also known as the Soai autocatalysis) stands among the most astonishing chemical experiments ever conducted. Thanks to the discoveries honored by the 2026 Nobel Prize in Chemistry, chemists now possess entirely new foundational tools for everyday work—but more importantly, these discoveries help solve one of chemistry’s greatest mysteries: how homochirality—the kind found universally in all living organisms—arises.

The 2026 Nobel Prize in Chemistry was awarded for 'chirality.' Are drug names containing 'left' or 'right' (e.g., levofloxacin and eszopiclone) applications of this principle?

Eszopiclone (marketed as 'right-zopiclone') is a similar case. Ordinary zopiclone contains a racemic mixture—a 1:1 pair of mirror-image molecules—whereas eszopiclone isolates the (+)-(S)-enantiomer.[2] That is, levofloxacin is 'levorotatory' and belongs to the S-configuration; eszopiclone is 'dextrorotatory' yet also belongs to the S-configuration. Here, two distinct nomenclature systems are involved: ・'Levorotatory' and 'dextrorotatory' refer to how a molecule rotates plane-polarized light—clockwise or counterclockwise—denoted respectively as '−' and '+'.[3] ・R and S denote the three-dimensional spatial arrangement of atoms within the molecule. II. Mirror-image molecules can indeed exhibit vastly different pharmacological effects. Although enantiomers share nearly identical chemical compositions, their distinct three-dimensional shapes cause them to bind differently to target sites—leading to marked differences in efficacy. Ofloxacin is a racemic mixture comprising levofloxacin (the S-enantiomer) and R-(+)-ofloxacin (which could be literally translated as 'dextrofloxacin'). ・One study comparing 801 microbial strains found that levofloxacin’s antibacterial activity was generally comparable to, or up to ~4-fold higher than, that of ofloxacin; another study on 506 Gram-positive bacterial strains showed levofloxacin’s overall antibacterial activity was approximately twice that of ofloxacin.[4,5] ・Moreover, the S-enantiomer’s antibacterial activity can be up to ~100-fold greater than that of the R-enantiomer—primarily due to differing abilities to inhibit bacterial DNA gyrase.[6] A similar phenomenon occurs with eszopiclone. ・According to FDA review documents, the S-enantiomer (eszopiclone) binds to the GABA_A receptor complex with roughly 50-fold greater affinity than its R-counterpart.[2] III. This year’s Nobel Prize research addresses 'left/right' selectivity—specifically, amplifying one chiral form. We already know that enantiomers often differ dramatically in biological effect. Yet conventional chemical reactions producing chiral molecules typically yield both mirror-image forms equally. For pharmaceuticals, fragrances, pesticides, and other products, however, we frequently desire only one enantiomer. The 2026 Nobel Prize in Chemistry was awarded to Henri B. Kagan and Kensō Soai 'for discovering nonlinear effects and autocatalysis in asymmetric organic synthesis.'[7] Kagan discovered that certain asymmetric reactions can amplify even minute initial imbalances in enantiomeric composition. Soai later identified a special reaction wherein the chiral product itself acts as a catalyst to generate more of the same enantiomer. In his landmark 1995 experiment, starting from just a 2% enantiomeric excess of one isomer, he amplified it to an 87% excess.[8] This solves the fundamental question: 'How can one mirror-image form become increasingly dominant?' Thus, a more precise statement is: Levofloxacin, eszopiclone, and the 2026 Nobel Prize in Chemistry all fall under the broad domain of chiral chemistry. The 'left' and 'right' in drug names illustrate *why* chirality affects drug efficacy; this year’s Nobel Prize, by contrast, illuminates *how* chemists selectively generate—and amplify—one chiral form during synthesis. References [1] U.S. Food and Drug Administration. LEVAQUIN (levofloxacin) Prescribing Information. 2020.

Scientists Win Chemistry Nobel for Discoveries About Mirrored Molecules That Led to Many Drugs

8 hours ago

French and Japanese scientists Henri B. Kagan and Kenso Soai won the Nobel Prize in Chemistry for developing methods to selectively produce mirror-image molecules, a breakthrough essential for creating countless modern drugs and transforming pharmaceutical science.

apnews

2026-10-08

Scientists Win Chemistry Nobel for Discoveries About Mirrored Molecules That Led to Many Drugs

Scientists Win Chemistry Nobel for Discoveries About Mirrored Molecules That Led to Many Drugs

FAQ